Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CAPI 3 Hb A1c

K-Number: K171537 · 2017-09-12

ApplicantSebia
Decision Date2017-09-12
Product CodePDJ
Advisory CommitteeCH
DecisionSubstantially Equivalent

Device Summary

CAPI 3 Hb A1c is a medical device manufactured by Sebia. It received FDA 510(k) clearance on 2017-09-12 under approval number K171537. The device is classified under product code PDJ. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CAPI 3 Hb A1c?

CAPI 3 Hb A1c is a medical device that received FDA 510(k) clearance on 2017-09-12. It is manufactured by Sebia. The 510(k) number is K171537.

When was CAPI 3 Hb A1c approved by the FDA?

CAPI 3 Hb A1c received FDA 510(k) clearance on 2017-09-12, under approval number K171537.

What company makes CAPI 3 Hb A1c?

CAPI 3 Hb A1c is manufactured by Sebia.

What is the FDA product code for CAPI 3 Hb A1c?

The FDA product code for CAPI 3 Hb A1c is PDJ.

Other Devices by Sebia

View all 12 devices →

Related Devices (Code: PDJ)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.